Parkway Eye Centre, a leading name in the ophthalmology sector, is headquartered in Singapore (SG) and serves a wide range of operational regions across Southeast Asia. Established in 2000, the centre has consistently set benchmarks in eye care, offering a comprehensive suite of services including cataract surgery, refractive surgery, and advanced diagnostic imaging. Renowned for its state-of-the-art technology and a team of highly skilled ophthalmologists, Parkway Eye Centre stands out for its patient-centric approach and commitment to excellence. The centre has achieved notable milestones, including accreditation from international health organisations, reinforcing its position as a trusted provider in the eye care industry. With a focus on innovation and quality, Parkway Eye Centre continues to lead the way in enhancing vision and improving the quality of life for its patients.
How does Parkway Eye Centre's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Parkway Eye Centre's score of 24 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Parkway Eye Centre, headquartered in Singapore (SG), currently does not have specific carbon emissions data available for the most recent year. The organisation is a current subsidiary of Parkway Pantai Limited, which is part of the IHH Healthcare Berhad group. As such, any emissions data or climate commitments may be influenced by the broader corporate strategies of these parent organisations. While there are no documented reduction targets or climate pledges specific to Parkway Eye Centre, it is important to note that the emissions data and climate initiatives may be cascaded from IHH Healthcare Berhad, which operates under various sustainability frameworks. The absence of specific emissions figures suggests that Parkway Eye Centre is still in the process of establishing its own climate commitments or may rely on the overarching strategies of its parent company. In the context of the healthcare industry, there is a growing emphasis on reducing carbon footprints and enhancing sustainability practices. Parkway Eye Centre's future climate commitments may align with industry standards and best practices as they develop their own initiatives.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 75,465,000 | 00,000,000 | 00,000,000 | 
| Scope 2 | 202,163,000 | 000,000,000 | 000,000,000 | 
| Scope 3 | - | 00,000,000 | 00,000,000 | 
Parkway Eye Centre's Scope 3 emissions, which increased by 90% last year and increased by approximately 90% since 2023, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 10% of total emissions under the GHG Protocol, with "Fuel and Energy Related Activities" being the largest emissions source at 247% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Parkway Eye Centre has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.